71
Views
54
CrossRef citations to date
0
Altmetric
Journal Article

Consequences on the newborn of chronic maternal consumption of coffee during gestation and lactation: a review.

&
Pages 6-21 | Published online: 04 Sep 2013

References

  • National Coffee Association of USA: “Coffee Drinking Study 1991.” New York: NCA of USA, 1991.
  • Nippon Research Center: “A Basic Survey for Monitoring Trends in the Demand for Coffee 1991.” Tokyo: All Japan Coffee Association, June 1991.
  • International Coffee Organization: “Coffee Consumption Habit Trends Data 1980 to 1990.” Federal Republic of Germany: ICO, July 1991.
  • D'Amicis A, Viani R: The consumption of coffee. In Garattini S (ed): “Coffee, Caffeine and Health.” New York: Raven Press, pp 1–16, 1993.
  • Peters A: Brewing makes the difference. San Francisco: Proceedings of the 14th International Scientific Colloquium on Coffee, pp 97–106, 1991.
  • Derby G: Le Café. Monographie n° 1. Nancy: Centre de Nutrition Humaine, 1987.
  • Arnaud MJ: The metabolism of coffee constituents. In Clarke RJ, Macrae R (eds): “Coffee, Vol 3: Physiology.” London: Elsevier Applied Publ, pp 33–55, 1988.
  • Arnaud MJ: Products of metabolism of caffeine. In Dews PB (ed): “Caffeine: Perspectives from Recent Research.” Berlin: Springer-Verlag, pp 3–38, 1984.
  • Arnaud MJ: The pharmacology of caffeine. Prog Drug Res 31: 273–313, 1987.
  • Arnaud MJ: Metabolism of caffeine and other components of coffee. In Garattini S (ed): “Coffee, Caffeine and Health.” New York: Raven Press, pp 43–94, 1993.
  • Arnaud MJ: Comparative metabolic disposition of [1-Me14C] caffeine in rats, mice and Chinese hamsters. Drug Metab Dispos 13: 471–478, 1985.
  • Berthou F, Guillois B, Riche C, Dreano Y, Jacqz-Aigrain E, Beaune PH: Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica 22: 671–680, 1992.
  • Blanchard J, Sawers SJA: The absolute bioavailability of caffeine in man. Eur J Clin Pharmacol 24: 93–98, 1983.
  • Bonati M, Latini R, Galetti F, Young TF, Tognoni G, Garattini S: Caffeine disposition after oral doses. Clin Pharmacol Ther 32: 98–106, 1982.
  • Parsons WD, Neims AH: Effect of smoking on caffeine clearance. Clin Pharmacol 24: 40–43, 1978.
  • Neims AH, Bailey J, Aldridge A: Disposition of caffeine during and after pregnancy (abstract). Clin Res 27: A236, 1979.
  • Patwardhan RV, Desmond PV, Johnson RF, Shenker S: Impaired elimination of caffeine by oral contraceptive steroids. J Lab Clin Med 95: 603–608, 1980.
  • Balogh A, Irmisch E, Klinger G, Splinter FK, Hoffmann A: Untersuchungen zur Elimination von Coffein und Metamizol im Menstruationszyclus der fertilen Frau. Zent Bl Gynäkol 109: 1135–1142, 1987.
  • Callahan MM, Robertson RS, Branfman AR, McComish MF, Yesair DW: Comparison of caffeine metabolism in three nonsmoking populations after oral administration of radiolabeled caffeine. Drug Metab Dispos 11: 211–217, 1983.
  • Abernethy A, Todd EL: Impairment of caffeine clearance by chronic use of low-dose estrogen-containing oral contraceptives. Eur J Clin Pharmacol 28: 425–428, 1985.
  • Aldridge A, Bailey J, Neims AH: The disposition of caffeine during and after pregnancy. Semin Perinatol 5: 310–318, 1981.
  • Brazier JL, Ritter J, Berland M, Khenfer D, Faucon G: Pharmacokinetics of caffeine during and after pregnancy. Dev Pharmacol Ther 6: 315–322, 1983.
  • Kling OR, Christensen DH: Caffeine elimination in late pregnancy. Fed Proc 38: 218–226, 1979.
  • Knutti R, Rothweiler H, Schlatter C: Effect of pregnancy on the pharmacokinetics of caffeine. Eur J Clin Pharmacol 21: 121–126, 1981.
  • Knutti R, Rothweiler H, Schlatter C: The effect of pregnancy on the pharmacokinetics of caffeine. Arch Toxicol 5: 187–192, 1982.
  • Parsons WD, Pelletier JG: Delayed elimination of caffeine by women in the last 2 weeks of pregnancy. Can Med Assoc J 127: 377–381, 1982.
  • Nakazawa K, Tanaka H, Arima M: The effect of caffeine ingestion on pharmacokinetics of caffeine and its metabolites after a single administration in pregnant rats. Pharmacobiol Dyn 8: 151–160, 1985.
  • Gilbert SG, So Y, Klassen RD, Geoffroy S, Stavric B, Rice DC: Elimination of chronically consumed caffeine in the pregnant monkey (Macaca fascicularis). J Pharmacol Exp Ther 239: 891–897, 1986.
  • Hogden GD, Stoufler RL, Barber DL, Nixon WE: Serum estradiol and progesterone during pregnancy and the status of the corpus luteum at delivery in cynomolgus monkeys (Macaca fascicularis). Steroids 30: 295–301, 1977.
  • Chandrashekar V, Wolf RC, Dierschke DJ, Scholl SA, Bridson WE, Clark JR: Serum progesterone and corpus luteum function in pregnant pigtailed monkeys (Macaca nemes-trina). Steroids 36: 483–495, 1980.
  • Petridou W, Katsouyanni K, Spanos E: Pregnancy estrogens in relation to coffee and alcohol intake. Ann Epidemiol 2: 241–247, 1992.
  • Rietveld EC, Brockmann MMM, Houben JJG, Eskes TKAB, Van Rossum JM: Rapid onset in an increase of caffeine residence time in young women due to oral contraceptive steroids. Eur J Clin Pharmacol 26: 371–373, 1984.
  • MacKinnon M, Sutherland E, Simon FR: Effects of ethinyl estradiol on hepatic microsomal proteins and the turnover of cytochrome P-450. J Lab Clin Med 90: 1096–1106, 1977.
  • Aranda JV, Collinge JM, Zinman R, Watters G: Maturation of caffeine elimination in infancy. Arch Dis Child 54: 946–949, 1979.
  • Paire M, Van Lieferinghen P, Desvignes V, Dubray C, Raynaud EJ, Lavarenne J: Cinétique de la caféine au cours des premiers mois de la vie et implications pratiques. Sem Hôp Paris 64: 1813–1817, 1988.
  • Aranda JV, MacLeod SM, Renton KW, Eade NR: Hepatic microsomal drug oxidation and electron transport in newborn infants. J Pediatr 85: 534–542, 1974.
  • Carrier O, Pons G, Rey E, Richard MO, Moran C, Badoual J, Olive G: Maturation of caffeine metabolic pathways in infancy. Clin Pharmacol Ther 44: 145–151, 1988.
  • Aldridge A, Aranda JV, Neims AH: Caffeine metabolism in the newborn. Clin Pharmacol Ther 25: 447–453, 1979.
  • Berthou F, Ratanasavanh D, Alix D, Carlhant D, Riche C, Guillouzo A: Caffeine and theophylline metabolism in newborn and adult human hepatocytes; comparison with adult rat hepatocytes. Biochem Pharmacol 37: 3691–3700, 1988.
  • Rivera-Calimlin L: Drugs in breast milk. Drug Ther 7: 59–63, 1977.
  • Parienta-Khayat A, Pons G, Rey E, Richard MO, D'Athis P, Moran C, Badoual J, Olive G: Caffeine acetylator phenotyping during maturation in infants. Pediatr Res 29: 492–495, 1991.
  • Aldridge A, Aranda JV, Neims AH: Caffeine metabolism in the newborn. Clin Pharmacol Ther 25: 447–453, 1979.
  • Aranda JV, Gorman W, Bergsteinsson H, Gunn T: Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr 90: 467–472, 1977.
  • Le Guennec JC, Billon B: Delay in caffeine elimination in breast-fed infants. Pediatrics 79: 264–268, 1987.
  • Parsons WD, Neims AH: Prolonged half-life of caffeine in healthy term newborn infants. J Pediatr 98: 640–641, 1981.
  • Pearlman SA, Duran CS, Wood MA, Maiseis MJ, Berlin CM: Caffeine pharmacokinetics in preterm infants older than 2 weeks. Dev Pharmacol Ther 12: 65–69, 1989.
  • Bonati M, Garattini S: Interspecies comparison of caffeine disposition. In Dews PB (ed): “Caffeine: Perspectives from Recent Research.” Berlin: Springer-Verlag, pp 48–56, 1984.
  • Bonati M, Latini R, Tognoni G, Young JF, Garattini S: Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse. Drug Metab Rev 15: 1355–1383, 1984–85.
  • Burg AW, Werner E: Tissue distribution of caffeine and its metabolites in the mouse. Biochem Pharmacol 21: 923–936, 1972.
  • Gilbert RM: Caffeine as a drug of abuse. In Gibbins RJ, Israel Y, Popham RE, Schmidt W, Smart RG (eds): “Research Advances in Alcohol and Drug Problems,” Vol 3. New York: John Wiley and Sons, pp 49–176, 1976.
  • Narod SA, De Sanjose S, Victora C: Coffee during pregnancy: a reproductive hazard? Am J Obstetr Gynecol 164: 1109–1114, 1991.
  • James JE: Human reproduction. In James JE (ed): “Caffeine and Health.” New York: Academic Press, pp 219–244, 1991.
  • Leviton A: Coffee, caffeine, and reproductive hazards in humans. In Garattini S (ed): “Coffee, Caffeine and Health.” New York: Raven Press, pp 343–356, 1993.
  • Purves D, Sullivan FM: Reproductive effects of caffeine. Experimental studies in animals. In Garattini S (ed): “Coffee, Caffeine and Health.” New York: Raven Press, pp 317–342, 1993.
  • Aeschbacher HU, Milon H, Würzner HP: Caffeine concentrations in mice plasma and testicular tissue and the effect of caffeine on the dominant lethal test. Mutat Res 57: 193–200, 1978.
  • Nolen GA: The effect of brewed and instant coffee on reproduction and teratogenesis in the rat. Toxicol Appl Pharmacol 58: 171–183, 1981.
  • Palm PE, Arnold EP, Rachwall PC, Leyczek JC, Teague KW, Kensler CJ: Evaluation of the teratogenic potential of fresh brewed coffee and caffeine in the rat. Toxicol Appl Pharmacol 44: 1–16, 1978.
  • Thayer PS, Kensler CJ: Exposure of four generations of mice to caffeine in drinking water. Toxicology 25: 169–179, 1973.
  • Epstein EE, Bass W, Arnold W, Bishop Y: The failure of caffeine to induce mutagenic effects or to synergize the effects of known mutagens in mice. Food Cosmet Toxicol 8: 381–401, 1970.
  • Bradford JC, Caldwell JA, Barbolt TA, Drobeck HP: Chronic administration of caffeine to two generations of rats. Teratology 27: 2–9, 1983.
  • Joesoef MR, Beral V, Rolfs RT, Aral SO, Cramer DW: Are caffeinated beverages risk factors for delayed conception? Lancet 335: 136–137, 1990.
  • Wilcox A, Weinberg C, Baird D: Caffeinated beverages and decreased fertility. Lancet 2: 1453–1455, 1988.
  • Persaud TVN: Caffeine. In Persaud TVN (ed): “Environmental Causes of Birth Defects.” Springfield: Charles C Thomas, pp 143–154, 1990.
  • Williams MA, Monson RR, Goldman MB, Mittendorf R, Ryan KJ: Coffee and delayed conception. Lancet 335: 1603, 1990.
  • Christianson RE, Oechsli FW, Van den Berg BJ: Caffeinated beverages and decreased fertility. Lancet 1: 378, 1989.
  • Olsen J: Cigarette smoking, tea and coffee drinking, and subfecundity. Am J Epidemiol 133: 734–739, 1991.
  • Butcher RE, Vorhees CV, Wooten V: Behavioral and physical development of rats chronically exposed to caffeinated fluids. Fund Appl Toxicol 4: 1–13, 1984.
  • Collins TFX, Welsh JJ, Black TN, Collins EV: A study of the teratogenic potential of caffeine given by oral intubation to rats. Regul Toxicol Pharmacol 1: 355–378, 1981.
  • Collins TFX, Welsh JJ, Black TN, Ruggles DI: A study of the teratogenic potential of caffeine ingested in drinking water. Food Chem Toxicol 21: 763–777, 1983.
  • Elmazar MMA, McElhatton PR, Sullivan FM: Studies on the teratogenic effects of different oral preparations of caffeine in mice. Toxicology 23: 57–71, 1982.
  • Murphy SJ, Benjamin CP: The effects of coffee on mouse development. Microbiol Lett 17: 91–100, 1981.
  • Smith SE, McElhatton PR, Sullivan FM: Effects of administering caffeine to pregnant rats either as a single daily dose or as divided doses four times a day. Food Chem Toxicol 25: 125–133, 1987.
  • Fujii T, Nishimura H: Adverse effects of prolonged administration of caffeine on rat fetus. Toxicol Appl Pharmacol 22: 449–457, 1972.
  • Fujii T, Sasaki H, Nishimura H: Teratogenicity of caffeine in mice related to its mode of administration. Jpn J Pharmacol 19: 134–138, 1969.
  • Ritter EJ, Scott WJ, Wilson JG, Mathinos PR, Randall JL: Potentiative interactions between caffeine and various teratogenic agents. Teratology 25: 95–100, 1982.
  • Scott WJ: Caffeine-induced limb malformations: description of malformation and quantification of placental transfer. Teratology 28: 427–435, 1983.
  • Gilbert SG, Rice DC, Reuhl KR, Stavric B: Adverse pregnancy outcome in the monkey (Macaca fascicularis) after chronic caffeine exposure. J Pharmacol Exp Ther 245: 1048–1053, 1988.
  • Weathersbee PS, Olsen L, Lodge JR: Caffeine and pregnancy: a retrospective survey. Postgrad Med 62: 64–69, 1977.
  • Srisuphan W, Bracken A: Caffeine consumption during pregnancy and association with late spontaneous abortion. Am J Obstet Gynecol 154: 14–20, 1986.
  • Graham DM: Caffeine: its identity, dietary sources, intake, and biological effects. Nutr Rev 36: 97–102, 1978.
  • Furuhashi N, Sato S, Suzuki M, Hiruta M, Tanaka M, Takahashi T: Effects of caffeine ingestion during pregnancy. Gynecol Obstet Invest 19: 187–191, 1985.
  • Mau G, Netter P: Kaffee- and Alkoholkonsum-Risikofaktoren in der Schwangerschaft? Geburtsh Frauenheilkd 34: 1018–1022, 1974.
  • Watkinson B, Fried PA: Maternal caffeine use before, during and after pregnancy and effects upon offspring. Neurobehav Toxicol Teratol 7: 9–17, 1985.
  • Linn S, Shoenbaum SC, Monson RR, Rosner B, Stubblefield PG, Ryan KJ: No association between coffee consumption and adverse outcomes of pregnancy. N Engl J Med 306: 141–145, 1982.
  • Berkowitz GS, Holford TR, Berkowitz RL: Effects of cigarette smoking, alcohol, coffee and tea consumption on preterm delivery. Early Hum Dev 7: 239–250, 1982.
  • Fenster L, Eskenazi B, Windham GC, Swan SH: Caffeine consumption during pregnancy and fetal growth. Am J Public Health 81: 458–461, 1991.
  • Olsen J, Overvad K, Frische G: Coffee consumption, birth-weight, and reproductive failures. Epidemiology 3: 370–374, 1991.
  • Armstrong BG, McDonald AD, Sloan M: Cigarette, alcohol, and coffee consumption and spontaneous abortion. Am J Public Health 82: 85–87, 1992.
  • McDonald AD, Armstrong BG, Sloan M: Cigarette, alcohol, and coffee consumption and prematurity. Am J Public Health 82: 87–90, 1992.
  • Williams MA, Mittendorf R, Stubblefield PG, Lieberman E, Shoenbaum SC, Monson RR: Cigarettes, coffee, and preterm rupture of the membranes. Am J Epidemiol 135: 895–903, 1992.
  • Nishimura H, Nakai K: Congenital malformations in offspring of mice treated with caffeine. Proc Soc Exp Biol Med 104: 140–142, 1960.
  • Nolen GA: The developmental toxicology of caffeine. In Kalter H (ed): “Issues and Reviews in Teratology,” Vol 4. New York: Plenum Press, pp 305–350, 1988.
  • Al-Hachim GM: Teratogenicity of caffeine: a review. Eur J Obstet Gynecol Reprod Biol 31: 237–247, 1989.
  • Berger A: Effects of caffeine consumption on pregnancy outcome. A review. J Reprod Med 33: 945–956, 1988.
  • Wilson JG, Scott WJ: The teratogenic potential of caffeine in laboratory animals. In Dews PB (ed): “Caffeine. Perspectives from Recent Research.” Berlin: Springer-Verlag, pp 165–187, 1984.
  • West GL, Sobotka TJ, Brodie RE, Beier JM, O'Connell MW Jr: Postnatal neurobehavioral development in rats exposed in utero to caffeine. Neurobehav Toxicol Teratol 8: 29–43, 1986.
  • Bertrand M, Girod J, Rigaud MF: Ectrodactylie provoquée par la caféine chez les rongeurs: rôle des facteurs spécifiques et génétiques. C R Soc Biol 164: 1488–1489, 1970.
  • Groupe D'Etude des Risques Tératogènes: Tératogénèse expérimentale: étude de la caféine chez la souris. Thérapie 24: 575–580, 1969.
  • Gilbert EF, Pistey WR: Effects on the offspring of repeated caffeine administration to pregnant rats. J Reprod Fertil 34: 495–499, 1973.
  • Jiritano L, Bortolotti A, Gaspari F, Bonati M: Caffeine disposition after oral administration to pregnant rats. Xenobiotica 15: 1045–1051, 1985.
  • Borlee L, Lechat MF, Bouckaert A, Misson C: Le café, facteur de risque pendant la grossesse? Louvain Méd 97: 279–284, 1978.
  • Jacobson MF, Goldman AS, Syme RH: Coffee and birth defects. Lancet 1: 1415–1416, 1981.
  • Kurppa K, Holmberg PC, Kuosma E, Saxen L: Coffee consumption during pregnancy and selected congenital malformations: A nationwide case-control study. Am J Public Health 73: 1387–1399, 1983.
  • Martin J: An overview: maternal nicotine and caffeine consumption and offspring outcome. Neurobehav Toxicol Teratol 4: 421–424, 1982.
  • Nelson MM, Forfar JD: Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J 1: 523–527, 1971.
  • Rosenberg L, Mitchell AA, Shapiro S, Slone D: Selected birth defects in relation to caffeine-containing beverages. JAMA 247: 1429–1432, 1982.
  • McDonald AD, Armstrong BG, Sloan M: Cigarette, alcohol, and coffee consumption and congenital defects. Am J Public Health 82: 91–93, 1992.
  • Kirkinen P, Jouppila P, Koivula A, Vuori J, Pukka M: The effect of caffeine on placental and fetal blood flow in human pregnancy. Am J Obstet Gynecol 147: 939–942, 1983.
  • Daval JL, Vert P: Effect of chronic exposure to methylxanthines on diazepam cerebral binding in female rats and their offsprings. Dev Brain Res 27: 175–180, 1986.
  • Gullberg EI, Ferrell F, Christensen HD: Effects of postnatal caffeine exposure through dam's milk upon weanling rats. Pharmacol Biochem Behav 24: 1695–1701, 1986.
  • Hughes RN, Beveridge IJ: Behavioral effects of prenatal exposure to caffeine in rats. Life Sci 38: 861–868, 1986.
  • Hughes RN, Beveridge IJ: Effects of prenatal exposure to chronic caffeine on locomotor and emotional behavior. Psychobiology 15: 179–185, 1987.
  • Hughes RN, De'Ath CP: Effect of prenatal caffeine on behaviour of young rats. IRCS Med Sci 11: 504–505, 1983.
  • Nakamoto T, Joseph F, Yazdani M, Hartman AD: Effects of different levels of caffeine supplemented to the maternal diet on the brains of newborn rats and their dams. Toxicol Lett 44: 167–175, 1988.
  • Peruzzi G, Lombardelli G, Abbrachio MP, Coen E, Cattabeni F: Perinatal caffeine treatment: behavioral and biochemical effects in rats before wearing. Neurobehav Toxicol Teratol 7: 453–460, 1985.
  • Dunlop M, Court JM: Effects of caffeine ingestion on neonatal growth in rats. Biol Neonate 39: 178–184, 1981.
  • Groisser DS, Rosso P, Winick M: Coffee consumption during pregnancy: subsequent behavioral abnormalities of the offspring. J Nutr 112: 829–832, 1982.
  • Holloway WR Jr: Caffeine: effects of acute and chronic exposure on the behavior of neonatal rats. Neurobehav Toxicol Teratol 4: 21–32, 1982.
  • Sobotka TJ, Spaid SL, Brodie RE: Neurobehavioral teratology of caffeine exposure in rats. Neurotoxicology 1: 403–416, 1979.
  • Caan BJ, Golhaber MK: Caffeinated beverages and low birthweight: a case-control study. Am J Public Health 79: 1299–1300, 1989.
  • Hogue CJ: Coffee in pregnancy. Lancet 1: 554, 1981.
  • Kuzma JW, Kissinger DG: Patterns of alcohol and cigarette use in pregnancy. Neurobehav Toxicol Teratol 3: 211–221, 1981.
  • Martin TR, Bracken MB: The association between low birth weight and caffeine consumption during pregnancy. Am J Epidemiol 126: 813–821, 1987.
  • Van den Berg BJ: Epidemiologic observations of prematurity: effects of tobacco, coffee and alcohol. In Reed DM, Stanley FJ (eds): “The Epidemiology of Prematurity.” Baltimore: Urban and Schwarzenberg, pp 157–176, 1977.
  • Brooke OG, Anderson HR, Bland JM, Peacock JL, Stewart CM: Effects on birth weight of smoking, alcohol, caffeine, socioeconomic factors, and psychosocial stress. Br Med J 298: 795–801, 1989.
  • Godel JC, Pabst HF, Hodges PE, Johnson KE, Froese GJ, Joffres MR: Smoking and caffeine and alcohol intake during pregnancy in a northern population: effect on fetal growth. Can Med Assoc J 147: 181–188, 1992.
  • Peacock JL, Bland JM, Anderson HR: Effects on birthweight of alcohol and caffeine consumption in smoking women. J Epidemiol Commun Health 45: 159–163, 1991.
  • Munoz L, Lönnerdal B, Dewey KG: Effect of maternal coffee consumption on maternal and infant hemoglobin and hematocrit (abstract). Fed Proc 46: 1015, 1987.
  • Munoz LM, Lönnerdal B, Keen CL, Dewey KG: Coffee consumption as a factor in iron deficiency anemia among pregnant women and their infants in Costa Rica. Am J Clin Nutr 48: 645–651, 1988.
  • Arnaud MJ, Bracco I, Sauvageat J, Clerc M: Placental transfer of the major caffeine metabolite in the rat using 6-amino-5[N-formylmithylamino]1,3[Me-14C]-dimethyluracil administered orally or intravenously to the pregnant rat. Toxicol Lett 16: 271–279, 1983.
  • Galli C, Spane PF, Szyzska K: Accumulation of caffeine and its metabolites in rat fetal brain and liver. Pharmacol Res Commun 7: 217–221, 1975.
  • Maickel RP, Snodgrass WR: Physicochemical factors in maternal-fetal distribution of drugs. Toxicol Appl Pharmacol 26: 218–230, 1973.
  • Tanaka H, Nakazawa K, Arima M, Iwasaki S: Caffeine and its dimethylxanthines and fetal cerebral development in rat. Brain Dev 6: 355–361, 1984.
  • Tanaka H, Nakazawa K, Arima M: Adverse effect of maternal caffeine ingestion on fetal cerebrum in rat. Brain Dev 5: 397–406, 1983.
  • Tanaka H, Nakazawa K, Arima M: Effects of maternal caffeine ingestion on the perinatal cerebrum. Biol Neonate 51: 332–339, 1987.
  • Yazdani M, Hartman AD, Miller HI, Temples TE, Nakamoto T: Chronic caffeine intake alters the composition of various parts of the brain in young growing rats. Dev Pharmacol Ther 11: 102–108, 1988.
  • Yazdani M, Joseph F Jr, Grant S, Hartman AD, Nakamoto T: Various levels of maternal caffeine ingestion during gestation affect biochemical parameters of fetal brain differently. Dev Pharmacol Ther 14: 52–61, 1990.
  • Nakamoto T, Hartman AD, Miller HI, Temples TE, Quinby GE Jr: Chronic caffeine intake by rat dams during gestation and lactation affects various parts of the neonatal brain. Biol Neonate 49: 277–283, 1986.
  • Nakamoto T, Joseph F Jr, Yazdani M, Hartman AD: Effects of different levels of caffeine supplemented to the maternal diet on the brains of newborn rats and their dams. Toxicol Lett 44: 167–175, 1988.
  • Nakamoto T, Roy G, Gottschalk SB, Yazdani M, Rossowska M: Lasting effects of early chronic caffeine feeding on rats' behavior and brain in later life. Physiol Behav 49: 721–727, 1991.
  • Nakamoto T, Gottschalk SB, Yazdani M, Joseph F Jr: Combined effects of caffeine and zinc in the maternal diet on fetal brains (abstract). FASEB 5, Part II:A1319, 1991.
  • Nakamoto T, Joseph F Jr: Interaction between caffeine and zinc on brain in newborn rats. Biol Neonate 60: 118–126, 1991.
  • Felipo V, Portoles M, Minana MD, Grisolia S: Rats that consume caffeine show decreased brain protein synthesis. Neurochem Res 11: 63–69, 1986.
  • Fuller GN, Divakaran P, Wiggins RC: The effects of postnatal caffeine administration on brain myelination. Brain Res 249: 181–191, 1982.
  • Quinby GE Jr, Batirbaygil Y, Hartman AD, Nakamoto T: Effects of orally administered caffeine on cellular response in protein energy-malnourished neonatal rat brain. Pediatr Res 19: 71–74, 1985.
  • Mori M, Wilber JF, Nakamoto T: Influences of maternal caffeine on the neonatal rat brains vary with the nutritional status. Life Sci 33: 2091–2095, 1983.
  • Mori M, Wilber JF, Nakamoto T: Protein-energy malnutrition during pregnancy alters caffeine's effect on brain tissue of neonate rats. Life Sci 35: 2553–2560, 1984.
  • Nakamoto T, Yazdani M: Interaction of caffeine and diets on fetal brain (abstract). Fed Proc 3: 579, 1986.
  • Yazdani M, Tran TH, Conley PM, Laurent J Jr, Nakamoto T: Effect of protein malnutrition and maternal caffeine intake on the growth of fetal rat brain. Biol Neonate 52: 86–92, 1987.
  • Koh CT, Zeman FJ: Effects of maternal caffeine exposure and protein malnutrition on the fetal rat (abstract). FASEB 3: A1252, 1989.
  • Nakamoto T, Hartman AD, Joseph F Jr: Interaction between caffeine intake and nutritional status on growing brains in newborn rats. Ann Nutr Metab 33: 92–99, 1989.
  • Enslen M, Milon H, Würzner HP: Brain catecholamines and sleep states in offspring of caffeine-treated rats. Experientia 36: 1105–1106, 1980.
  • Concannonn JT, Braughler JM, Schechter MD: Pre- and postnatal effects of caffeine on biogenic amines, cyclic nucleotides and behavior in developing rats. J Pharmacol Exp Ther 226: 673–679, 1983.
  • Yokogoshi H, Tani S, Amano N: The effects of caffeine and caffeine-containing beverages on the disposition of brain serotonin in rats. Agric Biol Chem 51: 3281–3286, 1987.
  • Tanaka H, Nakazawa K: Mental caffeine ingestion increases the tyrosine level in neonatal rat cerebrum. Biol Neonate 57: 133–139, 1990.
  • Ajarem JS, Ahmad M: Behavioral and biochemical consequences of perinatal exposure of mice to instant coffee: a correlative evaluation. Pharmacol Biochem Behav 40: 847–852, 1991.
  • Branchey L, Friedhoff AJ: Biochemical and behavioural changes in rats exposed to ethanol in utero. Ann NY Acad Sci 273: 328–330, 1991.
  • Kellogg C, Chisholum J, Simmons RD, Ison JR, Miller RK: Neural and behavioural consequences of prenatal exposure to diazepam. Monogr Neural Sci 9: 119–129, 1983.
  • Marangos PJ, Boulenger JP, Patel J: Effects of chronic caffeine on brain adenosine receptors: anatomical and ontogenetic studies. Life Sci 34: 899–907, 1984.
  • Guillet R, Kellogg C: Neonatal exposure to therapeutic caffeine alters the ontogeny of adenosine A1 receptors in brain of rats. Neuropharmacology 30: 489–496, 1991.
  • Hunter RE, Barrera CM, Donanich GP, Dunlap WP: Effects of uric acid and caffeine on A1 adenosine receptor binding in developing rat brain. Pharmacol Biochem Behav 35: 791–795, 1990.
  • Enslen M, Milon H, Würzner HP: Brain catecholamines and sleep states in offspring of caffeine-treated rats. Experientia 36: 1105–1106, 1980.
  • Würzner HP, Enslen M, Milon H: Prenatal effects of caffeine on sleep profile in rats. Salvador (Brazil): Proceedings of the 10th International Scientific Colloquium on Coffee, pp 309–317, 1982.
  • Sinton CM, Valatx JL, Jouvet M: Increased sleep time in the offspring of caffeine treated dams from two inbred strains of mice. Neurosci Lett 24: 169–174, 1981.
  • Holloway WR Jr, Thor DH: Caffeine: effects on the behavior of juvenile rats. Neurobehav Toxicol Teratol 5: 127–134, 1983.
  • Hughes RN, Beveridge IJ: Sex- and age-dependent effect of prenatal exposure to caffeine on open-field behavior, emergence latency and adrenal weights in rats. Life Sci 47: 2075–2088, 1990.
  • Lester D: Two tests of a fear-motivated theory of motivation. Psychonomic Sci 10: 385–386, 1968.
  • Sinton CM, Valatx JL, Jouvet M: Gestational caffeine modifies offspring behaviour in mice. Psychopharmacology 75: 69–74, 1981.
  • Guillet R: Neonatal caffeine exposure alters adenosine receptor control of locomotor activity in the developing rat. Dev Pharmacol Ther 15: 94–100, 1990.
  • Zimmerberg B, Carr KL, Scott A, Lee HH, Weider JM: The effects of postnatal caffeine exposure on growth, activity and learning in rats. Pharmacol Biochem Behav 39: 883–888, 1991.
  • Swenson RR, Beckwith BE, Lamberty KJ, Krebs SJ, Tinius TP: Prenatal exposure to AVP or caffeine but not oxytocin alters learning in female rats. Peptides 11: 927–932, 1990.
  • Hughes RN, Beveridge IJ: Behavioral effects of exposure to caffeine during gestation, lactation or both. Neurotoxicol Teratol 13: 641–647, 1991.
  • Sinton CM: Preliminary indications that functional effects of fetal caffeine exposure can be expressed in a second generation. Neurotoxicol Teratol 11: 357–362, 1989.
  • Baldwin HA, File SE, Johnston AL, Wilks LJ: An investigation of the acute, chronic and withdrawal effects of caffeine on anxiety, exploration and convulsions in the rat. Soc Neurosci Abstr 12: 907, 1986.
  • File SE: Diazepam and caffeine administration during the first week of life: changes in neonatal and adolescent behavior. Neurotoxicol Teratol 9: 9–16, 1987.
  • Barr HM, Streissguth AP, Martin DC, Herman CS: Infant size at 8 months of age: relationship to maternal use of alcohol, nicotine, and caffeine during pregnancy. Pediatrics 74: 336–341, 1984.
  • Streissguth AP, Barr HM, Martin DC, Herman CS: Effects of maternal alcohol, nicotine, and caffeine use during pregnancy on infant mental and motor development at eight months. Alcoholism Clin Exp Res 4: 152–164, 1980.
  • Van't Hoff W: Caffeine in pregnancy. Lancet 1: 1020, 1982.
  • Dumas M, Gouyon JB, Tenenbaum D, Michiels Y, Escousse A, Alison M: Systematic determination of caffeine plasma concentrations at birth in preterm and full-term infants. Dev Pharmacol Ther 4 [Suppl] 1: 182–186, 1982.
  • Jacobson SW, Fein GG, Jacobson JL, Schwartz PM, Dowler JK: Neonatal correlates of prenatal exposure to smoking, caffeine, and alcohol. Infant Behav Dev 7: 253–265, 1984.
  • Emory EK, Konopka S, Hronsky S, Tuggey R, Dave R: Salivary caffeine and neonatal behavior: assay modification and functional significance. Psychopharmacology 94: 64–68, 1988.
  • McGowan JD, Altman RE, Kanto WP: Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine. South Med J 81: 1092–1094, 1988.
  • Tang D, Lowry MF, Williams DG: Caffeine and babies. Br Med J 299: 121, 1990.
  • Barr HM, Streissguth AP: Caffeine use during pregnancy and child outcome: a 7-year prospective study. Neurotoxicol Teratol 13: 441–448, 1991.
  • Khanna NN, Somani SM: Maternal coffee drinking and unusually high concentrations of caffeine in the newborn. Clin Toxicol 22: 473–483, 1984.
  • Aranda JV, Cook CW, Gorman W, Aldridge A, Neims AH: Pharmacokinetic profile of caffeine in the premature infant with apnea. J Pediatr 94: 663–668, 1979.
  • Bairam A, Boutroy MJ, Badonnel Y, Vert P: Theophylline versus caffeine: comparative effects in the treatment of idiopathic apnea in the preterm infants. J Pediatr 110: 636–639, 1987.
  • Davis JM, Spitzer AR, Stegano JL, Bhutani V, Fox WW: Use of caffeine in infants unresponsive to theophylline in apnea of prematurity. Pediatr Pulmonol 3: 90–93, 1987.
  • De Carolis MP, Romagnoli C, Muzii U, Tortorolo G, Chiarotti M, De Giovanni N, Carnevale A: Pharmacokinetic aspects of caffeine in premature infants. Dev Pharmacol Ther 16: 117–122, 1991.
  • Scanlon JEM, Chin KC, Morgan MEI, Durbin GM, Hale KA, Brown SS: Caffeine or theophylline for neonatal apnea? Arch Dis Child 67: 425–428, 1992.
  • McGowan JD, Altman RE, Kanto WP: Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine. South Med J 81: 1092–1094, 1988.
  • Thomas DB: Neonatal abstinence syndrome. Med J Aust 148: 598, 1988.
  • McCulloch KM, Braun RJ, Simms PE, Evans MA, Kelly DH: Transplacentally acquired caffeine and the occurrence of apnea, bradycardia, and periodic breathing in preterm infants: preliminary communication. Pediatr Pulmonol 7: 66–70, 1989.
  • Toubas PL, Duke JC, McCaffree MA, Mattice CD, Bendell D, Orr WC: Effects of maternal smoking and caffeine habits on infantile apnea: a retrospective study. Pediatrics 78: 159–163, 1986.
  • Gould JB: SIDS: a sleep hypothesis. In Tilden JT, Roeder LM, Steinschneider A (eds): “Sudden Infant Death Syndrome.” New York: Academic Press, pp 443–452, 1993.
  • Würzner HP, Stalder R, Bexter A, Vuaraz L: Effects of drying and extraction rate of coffee in a multigeneration study in rats. Salvador (Brazil): “Proceedings of the 10th International Scientific Colloquium on Coffee, pp 355–362, 1982.
  • Munoz L, Keen CL, Lönnerdal B, Dewey KG: Coffee intake during pregnancy and lactation in rats: maternal and pup hematological parameters and liver iron, zinc and copper concentration. J Nutr 116: 1326–1333, 1986.
  • Munoz L, Lönnerdal B, Keen CL, Dewey KG: Effect of maternal coffee consumption on breast milk mineral concentrations (abstract). Am J Clin Nutr 45: 839, 1987.
  • Stavchansky S, Combs A, Sagraves R, Delgado M, Joshi A: Pharmacokinetics of caffeine in breast milk and plasma after single oral administration of caffeine to lactating mothers. Biopharm Drug Dispos 9: 285–299, 1988.
  • Bailey DN, Weiber RT, Naylor AJ: A study of salicylate and caffeine excretion in the breast milk of two nursing mothers. J Anal Toxicol 6: 64–68, 1982.
  • Berlin CM: Excretion of methylxanthines in human milk. Semin Perinatol 5: 389–394, 1981.
  • Berlin CM, Denson HM, Daniel CH, Ward RH: Disposition of dietary caffeine in milk, saliva, and plasma of lactating women. Pediatrics 73: 59–63, 1984.
  • Hill RM, Craig JP, Chaney MD, Tennyson LM, McCulley LB: Utilization of over-the-counter drugs during pregnancy. Clin Obstet Gynecol 20: 381–394, 1977.
  • Ryu JE: Caffeine in human milk and serum of breast fed infants. Dev Pharmacol Ther 8: 329–337, 1985.
  • Sargraves R, Bradley JM, Delgado MJM, Wagner D, Sharpe GL, Stavchansky S: Pharmacokinetics of caffeine in human breast milk after a single oral dose of caffeine (abstract). Drug Intell Clin Pharm 18: 507, 1984.
  • Tyrala EE, Dodson WE: Caffeine secretion in breast milk. Arch Dis Child 54: 787–800, 1979.
  • Goujard J, Darchy P, Crost M: L'enfant à la maternité. In Rumeau-Rouquette C, Du Mazaubrun C, Rabarison Y (eds): “Naître en France. 10 Ans d'Evolution 1972–1981.” Paris: Editions INSERM, Doin Editeurs, pp 91–99, 1984.
  • Deschamps JP: En Meurthe-et-Moselle, les mères allaitent plus qu'ailleurs. Cahiers de Promotion de la Santé dans le Nord-Est 6: 21–22, 1986.
  • Martinez GA, Dodd DA, Samartgedes JA: Milk feeding patterns in the United States during the first 12 months of life. Pediatrics 68: 863–868, 1981.
  • Lawrence RA: Drugs in breast milk and the effect on the infant. In Lawrence RA (ed): “Breast-Feeding: A Guide for the Medical Profession,” 3rd ed. St Louis: CV Mosby, pp 518–595, 1989.
  • Deblay MF, Vert P: Passage des médicaments dans le lait maternel. Concours Médical 108: 279–283, 1986.
  • Blanchard J, Weber CW, Shearer LE: Methylxanthine levels in breast milk of lactating women of different ethnic and socioeconomic classes. Biopharm Drug Dispos 13: 187–196, 1992.
  • Nagasawa H, Sakurai N: Effects of chronic ingestion of caffeine on mammary growth and reproduction in mice. Life Sci 39: 351–357, 1986.
  • Hart AD, Grimble RF: The effect of methylxanthines on milk volume and composition, and growth of rat pups. Br J Nutr 64: 339–350, 1990.
  • Morck TA, Lynch SR, Cook J: Inhibition of iron absorption by coffee. Am J Clin Nutr 37: 416–420, 1983.
  • Beaulac-Baillargeon L, DesRosiers C: Profil de la consommation de caféine, de cigarettes et d'alcool par les femmes québecoises pendant la grossesse (abstract). Union Méd Can 115: 813, 1986.
  • Istvan J, Matarazzo JD: Tobacco, alcohol, and caffeine use: a review of their interrelationships. Psychol Bull 95: 301–324, 1984.
  • Bavoux F, Francoual C, Warot D: Médicaments et allaitement. Rev Prat 36: 1519–1537, 1986.
  • Roberts RJ: Methylxanthine therapy: caffeine and theophylline. In Roberts RJ (ed): “Drug Therapy in Infants, Pharmacological Principles and Clinical Experience.” Philadelphia: WB Saunders, pp 119–137, 1984.
  • Lelo A, Miners JO, Robson R, Birkett DJ: Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentration of methylxanthines. Clin Pharmacol Ther 39: 54–59, 1986.
  • Hart AD, Grimble RF: Effect of methylxanthines on lactational performance of rats. Ann Nutr Metab 34: 296–302, 1990.
  • Sheffield LG: Caffeine administered during pregnancy augments subsequent lactation in mice. J Anim Sci 69: 1128–1134, 1991.
  • Naismith DJ, Richardson DP, Pritchard AE: The utilisation of protein and energy during lactation in the rat, with particular regard to the use of fat accumulated in pregnancy. Br J Nutr 48: 433–441, 1982.
  • Moore BJ, Brasel JA: One cycle of reproduction consisting of pregnancy, lactation or no lactation and recovery: effects on carcass composition in ad lib-fed and food restricted rats. J Nutr 114: 1548–1559, 1984.
  • Bellet S, Kershbaum A, Finck EM: Response of free fatty acids to coffee and caffeine. Metabolism 17: 702–707, 1968.
  • Bellet S, Roman L, Decastro I, Kim KE, Kershbaum A: Effect of coffee ingestion on adrenocortical secretion in young men and dogs. Metabolism 18: 1007–1012, 1969.
  • Patwardhan RV, Desmond PV, Johnson RF, Dunn D, Robertson E, Hoyumpa AM, Shenker S: Effect of caffeine on plasma free fatty acids, urinary catecholamines and drug binding. Clin Pharmacol Ther 28: 398–403, 1980.
  • Enslen M, Gueye C: Effets de la caféine sur le comportement maternel chez le rat. Lomé (Togo): “Proceedings of the 11th International Scientific Colloquium on Coffee, pp 155–162, 1985.
  • Milon H: Effects of caffeine on maternal behaviour: biochemical study. Lomé (Togo): “Proceedings of the 11th International Scientific Colloquium on Coffee, pp 163–168, 1985.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.